GlassScriptPhysician profile
Lori E Helgesen
NPI 1700154929
$801.28
in general payments reported to CMS, 2019-2025
18 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $213 · 2024: $347 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $100.49 | 2023-2025 | Repatha, Otezla, Otezla |
| Pfizer INC. | $98.39 | 2024-2025 | |
| Exact Sciences Corporation | $85.14 | 2024-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $81.80 | 2023-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| E.R. Squibb & Sons, L.L.C. | $67.46 | 2023-2024 | Camzyos, Eliquis |
| Otsuka America Pharmaceutical, INC. | $66.76 | 2023-2024 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.32 | 2024-2025 | Caplyta |
| Novo Nordisk INC | $36.36 | 2023-2024 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $35.96 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Astrazeneca Pharmaceuticals LP | $29.81 | 2024-2025 | Airsupra |
| Lilly USA, LLC | $28.08 | 2023 | Jardiance, Emgality |
| Sanofi Pasteur INC. | $27.02 | 2023 | |
| Radius Health, INC. | $19.38 | 2025 | Tymlos |
| Lundbeck LLC | $18.21 | 2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.62 | 2024 | Xifaxan |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $17.40 | 2024 | Inspire |
| Axsome Therapeutics, INC. | $16.10 | 2025 | Auvelity |
| Abbvie INC. | $14.98 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Helgesen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.